352770 — Celestra Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Celestra, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 55,426 | 23,083 | 11,408 | 8,502 | 2,008 |
| Cost of Revenue | |||||
| Gross Profit | 37,413 | 8,238 | 289 | -1,182 | 1,014 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32,499 | 33,858 | 47,248 | 53,837 | 16,267 |
| Operating Profit | 22,927 | -10,775 | -35,840 | -45,335 | -14,259 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 24,819 | -10,122 | -42,431 | -47,089 | -11,771 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 15,853 | -10,234 | -42,399 | -47,055 | -11,771 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 15,853 | -10,177 | -42,257 | -46,925 | -11,771 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 14,204 | -10,177 | -42,257 | -46,925 | -11,771 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 8,137 | -6,442 | -23,074 | -14,746 | -1,909 |
| Dividends per Share |